Internal Medicine, Rheumatology · Lakeland, FL
NPI
1982600417
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
130 Pablo St
Lakeland, FL, 33803
Phone (863) 284-5941
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
2,589 services
Medicare patients, 2024
261
Average age 75
Drug cost, 2024
$5.6M
5,310 prescriptions
Company payments, 2025
$457
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raul Tallo was code 99213 (office e&m - established), 347 times for 204 patients. In total Raul Tallo billed 2,589 services in 35 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 347 | 204 | $44.29 | $15K |
| 85652 Clinical Chemistry | Office | 296 | 133 | $2.64 | $780 |
| 99214 Office E&M - Established | Office | 291 | 180 | $67.44 | $20K |
| 85025 Blood Count | Office | 256 | 113 | $7.61 | $1,948 |
| 86140 Clinical Chemistry | Office | 250 | 115 | $5.08 | $1,270 |
| 82565 Clinical Chemistry | Office | 186 | 97 | $5.02 | $934 |
| 84460 Clinical Chemistry | Office | 161 | 85 | $5.19 | $836 |
| 84075 Clinical Chemistry | Office | 161 | 85 | $5.08 | $818 |
| 84450 Clinical Chemistry | Office | 161 | 85 | $5.08 | $818 |
| 80053 Clinical Chemistry | Office | 141 | 82 | $10.35 | $1,459 |
| 36415 Venipuncture Blood Collection | Office | 109 | 74 | $7.32 | $797 |
| 20610 Joint Injection | Office | 60 | 38 | $35.99 | $2,159 |
| 82306 Clinical Chemistry | Office | 56 | 45 | $29.01 | $1,625 |
| 84550 Clinical Chemistry | Office | 21 | 17 | $4.43 | $93.03 |
By year: 2022 $70K for 2,967 services; 2023 $63K for 2,844 services; 2024 $52K for 2,589 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85652 Clinical Chemistry | 296 | 133 | $2.64 | $780 |
| 85025 Blood Count | 256 | 113 | $7.61 | $1,948 |
| 86140 Clinical Chemistry | 250 | 115 | $5.08 | $1,270 |
| 82565 Clinical Chemistry | 186 | 97 | $5.02 | $934 |
| 84450 Clinical Chemistry | 161 | 85 | $5.08 | $818 |
| 84075 Clinical Chemistry | 161 | 85 | $5.08 | $818 |
| 84460 Clinical Chemistry | 161 | 85 | $5.19 | $836 |
| 80053 Clinical Chemistry | 141 | 82 | $10.35 | $1,459 |
| 36415 Venipuncture Blood Collection | 109 | 74 | $7.32 | $797 |
| 82306 Clinical Chemistry | 56 | 45 | $29.01 | $1,625 |
Medicare prescription drug claims, 2024
In 2024, the drug Raul Tallo prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,026 prescriptions and refills. In total Raul Tallo wrote 5,310 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,026 | 1,633 | 191 | $13K |
| Prednisone Generic | 599 | 1,019 | 178 | $4,064 |
| Hydroxychloroquine Sulfate Generic | 498 | 1,124 | 125 | $13K |
| Humira(Cf) Pen Adalimumab | 262 | 262 | 33 | $1.9M |
| Celecoxib Generic | 225 | 371 | 66 | $5,217 |
| Tramadol Hcl Generic | 199 | 200 | 34 | $1,811 |
| Alendronate Sodium Generic | 191 | 496 | 70 | $1,120 |
| Folic Acid Generic | 146 | 405 | 46 | $1,269 |
| Gabapentin Generic | 136 | 220 | 31 | $1,600 |
| Mycophenolate Mofetil Generic | 122 | 158 | 21 | $10K |
| Leflunomide Generic | 95 | 154 | 26 | $3,333 |
| Leucovorin Calcium Generic | 93 | 244 | 33 | $3,148 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 90 | 120 | 25 | $1,102 |
| Duloxetine Hcl Generic | 85 | 148 | 17 | $977 |
| Allopurinol Generic | 85 | 206 | 22 | $774 |
Brand drugs: 893 claims; generic drugs: 4,403 claims; opioid claims: 324.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raul Tallo $457 ($457 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $184.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.